ARTICLE | Company News
Searle extends alliance with Myriad
January 20, 2000 8:00 AM UTC
Searle extended its relationship with MYGN to use its ProNet protein interaction technologies for drug target discovery and expanded the collaboration from two to three disease pathways. Under the ext...